Remdesivir (GS-5734) Coronavirus COVID-19
We offer
Remdesivir (GS-5734) is a nucleoside analogue, with effective antiviral activity, with EC50s of 74 nM for SARS-CoV and MERS-CoV in HAE cells, and 30 nM for murine hepatitis virus in delayed brain tumor cells. Recently it is being studied as a promising medication for the treatment of COVID-19 (new SARS type virus).
This compound is for laboratory research use only. NOT FOR HUMAN USE.
COA available.
Characterisation:
Remdesivir (GS-5734)
CAS: 1809249-37-3
Appearance/Purity: White to off-white crystalline powder
IUPAC Name: 2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate
Other names: GS 5734; DB14761; SB19838, Remdesivir
Molecular weight: 602.58 g/mol
Molecular formula:C27H35N6O8P
COA available
******* WARNING******
Our product Remdesivir is a Pure chemical in Powder form for laboratory research use only. NOT FOR HUMAN OR PATIENT USE.
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View